E-cadherin expression in pancreatic cancer and its clinical significance
ZHOU Xiao-hui,XU Bin,WANG Dan-song,LOU Wen-hui,JIN Da-yong
DOI: https://doi.org/10.3969/j.issn.1007-9610.2007.03.015
2007-01-01
Abstract:Objective To investigate the expression of E-cadherin in human pancreatic cancer tissues,and its cli-nical implication.Methods The expression of E-cadherin in 60 patients with pancreatic cancer admitted during the priod from January 2001 to June 2006,was determined by tissue microarray and EnVision immunohistochemical staining.Results The expression of E-cadherin in the memberane of normal pancreatic cells was higher than that in cancer cells.The rate of reduced E-cadherin expression in pancreatic cancer tissues was 61.7%(37/60).The reduced E-cadherin expression was closely related with cancerous tissue differentiation,lymph node status,TNM stage and poor prognosis(P<0.05).Conclusions E-cadherin might be a sensitive predictor to evaluate the metastasic potential and the outcome of pancreatic cancer patients.
What problem does this paper attempt to address?